The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG®), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT).
about
The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG®), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The anticoagulant effect of th ...... nd Ecarin Clotting Time (ECT).
@en
The anticoagulant effect of th ...... nd Ecarin Clotting Time (ECT).
@nl
type
label
The anticoagulant effect of th ...... nd Ecarin Clotting Time (ECT).
@en
The anticoagulant effect of th ...... nd Ecarin Clotting Time (ECT).
@nl
prefLabel
The anticoagulant effect of th ...... nd Ecarin Clotting Time (ECT).
@en
The anticoagulant effect of th ...... nd Ecarin Clotting Time (ECT).
@nl
P2093
P2860
P1476
The anticoagulant effect of th ...... and Ecarin Clotting Time (ECT)
@en
P2093
Annette Schophuus Jensen
Christian Maschmann
Jakob Stensballe
Sacha Solbeck
P2860
P356
10.1080/00365513.2017.1408138
P577
2018-01-05T00:00:00Z